Lion Tcr

Developer of T-cell therapeutics for the treatment of viral infections

placeSingapore, Singapore, Singapore calendar_todayFounded 2015 groups32 employees language liontcr.com

Registered entities

Investor mix

25 investors on record; lead investors include Westlake Ventures, ABC Capital.

Investor typeCountShare
Venture capital312%
Private equity28%
Other / undisclosed2080%
Coming soon